TCL Archive Progression-free survival as a primary endpoint for drug approval requires prospective planning, FDA’s Pazdur says. May 7, 2004
TCL Archive Rauscher, ACS Oppose Kennedy Bill, Defend NCI Special Authority, Say Funding Level Inadequate May 11, 1979